Navigating complications of disease-modifying anti-rheumatic drugs at the 'front door'
Singh, Ruchir Croft, Adam P
Singh, Ruchir
Croft, Adam P
Affiliation
Other Contributors
Publication date
2025-08-20
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Disease-modifying anti-rheumatic drugs (DMARDs) have revolutionised the treatment landscape in rheumatology, reducing both disease severity and the risk of systemic co-morbidities. These immunomodulatory drugs have been re-purposed for use in other chronic inflammatory diseases, conferring further advantages. However, DMARDs can be associated with adverse events that have implications for the management of common symptoms and conditions that present to medical services at the 'front door'.
Citation
Singh R, Croft AP. Navigating complications of disease-modifying anti-rheumatic drugs at the 'front door'. Clin Med (Lond). 2025 Aug 20:100504. doi: 10.1016/j.clinme.2025.100504.
Type
Review